104 related articles for article (PubMed ID: 12148200)
1. [Epidemiology and natural history of schizophrenia].
Clervoy P; Corcos M
Rev Prat; 2002 Jun; 52(11):1177-82. PubMed ID: 12148200
[TBL] [Abstract][Full Text] [Related]
2. Positive family history is associated with persistent elevated emotional distress in schizophrenia: evidence from a 16-month follow-up study.
Ritsner MS; Ratner Y; Gibel A; Weizman R
Psychiatry Res; 2007 Dec; 153(3):217-23. PubMed ID: 17675246
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia and urbanicity: a major environmental influence--conditional on genetic risk.
Krabbendam L; van Os J
Schizophr Bull; 2005 Oct; 31(4):795-9. PubMed ID: 16150958
[TBL] [Abstract][Full Text] [Related]
4. Reconciling 'the new epidemiology' with an evolutionary genetic basis for schizophrenia.
Burns JK
Med Hypotheses; 2009 Mar; 72(3):353-8. PubMed ID: 19028022
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia and bipolar disorder: similarities in pathogenic mechanisms but differences in neurodevelopment.
Walker J; Curtis V; Murray RM
Int Clin Psychopharmacol; 2002 Aug; 17 Suppl 3():S11-9. PubMed ID: 12570067
[TBL] [Abstract][Full Text] [Related]
6. Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.
Lieberman JA; Malaspina D; Jarskog LF
CNS Spectr; 2006 Apr; 11(4):suppl 1-13; quiz suppl 14-5. PubMed ID: 16641837
[TBL] [Abstract][Full Text] [Related]
7. Interaction of genetic vulnerability to schizophrenia and Communication Deviance of adoptive parents associated with MMPI schizophrenia vulnerability indicators of adoptees.
Siira V; Wahlberg KE; Hakko H; Läksy K; Tienari P
Nord J Psychiatry; 2007; 61(6):418-26. PubMed ID: 18236307
[TBL] [Abstract][Full Text] [Related]
8. [Presentations and diagnostic criteria of schizophrenia].
Corcos M; Clervoy P; Jeammet P
Rev Prat; 2002 Jun; 52(11):1183-90. PubMed ID: 12148201
[TBL] [Abstract][Full Text] [Related]
9. Precursors and prodromata of schizophrenia: findings from the Edinburgh High Risk Study and their literature context.
Owens DG; Johnstone EC
Psychol Med; 2006 Nov; 36(11):1501-14. PubMed ID: 16817986
[TBL] [Abstract][Full Text] [Related]
10. Cannabis use and genetic predisposition for schizophrenia: a case-control study.
Veling W; Mackenbach JP; van Os J; Hoek HW
Psychol Med; 2008 Sep; 38(9):1251-6. PubMed ID: 18485264
[TBL] [Abstract][Full Text] [Related]
11. The transmission of risk to children from mothers with schizophrenia: a developmental psychopathology model.
Wan MW; Abel KM; Green J
Clin Psychol Rev; 2008 Apr; 28(4):613-37. PubMed ID: 17928115
[TBL] [Abstract][Full Text] [Related]
12. Parental age and risk of schizophrenia: a case-control study.
Byrne M; Agerbo E; Ewald H; Eaton WW; Mortensen PB
Arch Gen Psychiatry; 2003 Jul; 60(7):673-8. PubMed ID: 12860771
[TBL] [Abstract][Full Text] [Related]
13. Neural correlates of enhanced genetic risk for schizophrenia.
Whalley HC; Whyte MC; Johnstone EC; Lawrie SM
Neuroscientist; 2005 Jun; 11(3):238-49. PubMed ID: 15911873
[TBL] [Abstract][Full Text] [Related]
14. [Neurodevelopmental hypothesis of schizophrenia].
Franck N; Georgieff N
Rev Prat; 2002 Jun; 52(11):1202-7. PubMed ID: 12148205
[TBL] [Abstract][Full Text] [Related]
15. fMRI changes over time and reproducibility in unmedicated subjects at high genetic risk of schizophrenia.
Whalley HC; Gountouna VE; Hall J; McIntosh AM; Simonotto E; Job DE; Owens DG; Johnstone EC; Lawrie SM
Psychol Med; 2009 Jul; 39(7):1189-99. PubMed ID: 19105855
[TBL] [Abstract][Full Text] [Related]
16. [Functional polymorphism of manganese superoxide dismutase (MnSOD) gene correlates with schizophrenia in Polish population].
Gałecki P; Pietras T; Szemraj J; Florkowska K; Florkowski A; Zboralski K
Pol Merkur Lekarski; 2006 Mar; 20(117):329-32. PubMed ID: 16780268
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychology, genetic liability, and psychotic symptoms in those at high risk of schizophrenia.
Byrne M; Clafferty BA; Cosway R; Grant E; Hodges A; Whalley HC; Lawrie SM; Owens DG; Johnstone EC
J Abnorm Psychol; 2003 Feb; 112(1):38-48. PubMed ID: 12653412
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenia: who is at risk? Who is a case?
Verdoux H; Cougnard A
Int Clin Psychopharmacol; 2006 Mar; 21 Suppl 2():S17-9. PubMed ID: 16601509
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for schizophrenia--all roads lead to dopamine.
Di Forti M; Lappin JM; Murray RM
Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S101-7. PubMed ID: 17336764
[TBL] [Abstract][Full Text] [Related]
20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
